Table 2.
Prognostic role of miR-4295 in different cancers.
| Cancer type | Sample | Factors | Relationship | Reference |
|---|---|---|---|---|
| NSCLC | Survival of NSCLC patients from Kaplan–Meier Plotter database | OS | Negative correlation | 20 |
| Gliomas | 20 matched patients | Clinical stage | Positive correlation | 37 |
| HNSCC | 92 matched patients | Clinical stage, Tumor size, TNM stage, lymphatic metastasis OS |
Positive correlation Negative correlation |
43 43 |
| BC | 564 high miR-4295 expression patients and 186 lower expression of miR-4295 patients from Kaplan–Meier Plotter database | OS | Positive correlation | 41 |
| NSCLC | 53 high USP28 expression patients and 17 lower expression of USP28 | OS | Positive correlation | 14 |
NSCLC: non-small cell lung cancer; BC: bladder cancer; HNSCC: head and neck squamous cell carcinoma; OS: overall survival.